Weekly Industry News – Pharma & Healthcare

  Pharma & Healthcare – the latest on DEA probe, False Claims Act, Pfizer and more.

Costco says cooperating with DEA probe on controlled substances by Jessica Wohl  Editing by Leslie Adler and Bob Burgdorfer Posted on Reuters

Costco Wholesale Corp (COST.O) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA. The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected… [ Read More ]

Supreme Court Considering False Claims Act Appeal by Brian Mahany Posted on jdsupra.com

The Supreme Court is considering an appeal from the 4th Circuit regarding the specificity necessary when pleading false claims act cases. The issue has serious implications for whistleblowers who can only document indirect frauds against government programs… [ Read More ]  

Early Promise in Drug Trial for Fighting Cholesterol by Andrew Pollack Posted on the NYTimes.com

A new type of lipid-lowering drug being developed by Sanofi and Regeneron Pharmaceuticals cut cholesterol levels by about half in its first late-stage clinical trial, the companies will announce on Wednesday. The drug, called alirocumab, is one of a new class of potentially powerful cholesterol fighters that have excited doctors and investors alike, spurring a heated race to market among Sanofi, Amgen, Pfizer and other companies… [ Read More ]  

Pfizer gets European approval for label update of pneumococcal conjugate vaccine Prevenar 13 by pharmaceutical-technology Posted on pharmaceutical-technology

Pfizer has received European Commission approval for updates to the summary of product characteristics (SmPC) for its pneumococcal conjugate vaccine (PCV) Prevenar 13, regarding its use in certain high-risk populations. The updated label now contains information about the use of Prevenar 13 in preterm infants, children and adolescents with sickle cell disease who were earlier treated with the 23-valent pneumococcal polysaccharide vaccine…[ Read More]  

                                                         Related Events

  Rx Drug PricingFDA Boot Camp - Devices EditionManaged Care Disputes and Litigation False Claims - Legal Conference Controlled Substances cGMP - Legal Conferences   For a complete list of all Pharma related events: Click Here For a complete list of all Healthcare related events: Click Here For a complete list of all Pharma conference proceedings: Click Here  For a complete list of all Healthcare conference proceedings: Click Here